Gene Logic is a leading integrated genomics company providing comprehensive Genomic Reference Databases and GLP compliant Microarray Services. Over 2/3rd of the top 25 Pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred genomics partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets & biomarkers.

Ronglian Group Ltd. engages in design, development, and sale of information technology systems. It provides data center and information technology infrastructure solutions, cloud computing, enterprise mobile applications, software development, business consulting and other professional services. The company was founded by Dong Hui Wang on March 12, 2001 and is headquartered in Beijing, China.

Develops pharmaceutical products

Zhiben Medical Technology (Shanghai) Co. Ltd. (doing business as OrigiMed) is a company headquartered in Shanghai, China. The firm develops medical science and technology transforming application. It was founded in 2016.\nThe company says this about itself: OrigiMed is a precision medicine company focusing on high-tech R&D with a global vision and the knowledge transfer in the clinical practice of cancers. With the commitment to developing hundreds of cancer genomic tests, the company strive to provide comprehensive and accurate molecular information to every patient and help doctors with their precision medicine practice. OrigiMed aims to promote the innovation in the way of clinical treatment for cancer in China. At OrigiMed, patients' molecular changes are identified by the stringently verified CGP and matched with approved targeted therapies, immunotherapies, and clinical trials. OrigiMed closely collaborates with global and domestic biopharmaceutical companies to help with new drug development and approvals.

Shanghai Zhiben Medical Laboratory Co., Ltd., established on 2017-05-04, Business scope includes for-profit medical institutions,Engaged in the field of biotechnology and a class,Class II,Technology development of three types of medical devices,technology transfer,technical consulting,Technical Services,one type,Class II,Class III Medical Devices,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Shenzhen is a high-tech firm dedicated to the application of human micro-ecological technology to develop solutions for a healthy life. It also offers solutions for clinical research and the diagnosis and treatment of diseases.

BGI Tech Solutions Co., Ltd. (BGI-Tech), is a world leader in cutting-edge life sciences technology and premier scientific partner to the global research community. With a firm commitment to providing the highest quality services through our worldwide service network, BGI-Tech’s mission is to facilitate ground-breaking research, foster productive collaboration and accelerate scientific advancement. BGI-Tech was founded in 2012 and is headquartered in Shenzhen, China. BGI-Tech has lab facilities in Hong Kong, Wuhan (China),and Sacramento, California (United States). It also has branch offices in Europe, the Americas, Asia- Pacific, and in Beijing, Shanghai, and Guangzhou of mainland China. Its service network covers more than 100 countries and regions. Currently, BGI-Tech collaborates with over 10,000 organizations and 30,000 partners, providing highly reliable services for thousands of research projects, including several large-scale international genome projects. With diverse service experience, unique scientific expertise, BGI-Tech is committed to developing integrated omics platforms to revolutionize life science research, to accelerate the advancement of the life science industry and to address various health, agricultural, energy, and environmental issues to improve life and society.

Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.

Beijing Anngeen Biotechnology Co., Ltd. is a Chinese company located in Beijing. The firm provides solutions to genetic disease detection. It was founded in 2017.

Genemo Inc. is a biotech startup located at San Diego. Founded in 2015 by professors and researchers from UCSD, it focuses on developing ultra-sensitive RNA detection technologies, and fulfilling its application in diagnostic tools development. Genemo has established two unique ultra-sensitive RNA detection platforms. One is Mos-Seq Serum. It is an NGS-based RNA-seq technology that enables people to quantitatively measure gene expression information from only 7µL of serum samples. The other platform is Lucid RNA. It is an improved single-molecule FISH (fluorescence in situ hybridization) technology, capable of highly specific identification of RNA molecules at an extremely sensitive level. Supporting its ambitious vision, Genemo’s development team comprises a diverse set of talented individuals from backgrounds ranging from molecular biology, genetics, computer sciences, physics and electrical engineering. The board members and advisors come from academia and industry, each with a distinguished record.

Guangzhou Codon Gene Technology Co., Ltd., established on 2016-09-07, Business scope includes biotechnology extension services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;New material technology promotion service;New material technology development service;New material technical consultation,communication service;New material technology transfer service;Natural science research and experimental development;Human Science Research,to develop;Health Sciences Program Research,to develop;Stem Cell Technology Research,to develop;Medical Research and Experimental Development;Gene drug development;Engineering and Technology Research and Experimental Development;Wholesale of chemical products(Excluding hazardous chemicals);Commodity wholesale trade(Except for licensed and approved products);Instrument wholesale;

Guangzhou Jisai Biotechnology Co., Ltd., established on 2010-06-08, The scope of business includes the manufacture of special equipment for teaching;Health Sciences Program Research,to develop;Medical Research and Experimental Development;Gene drug development;Stem Cell Technology Research,to develop;Natural science research and experimental development;Human Science Research,to develop;Instrument wholesale;Commodity wholesale trade(Except for licensed and approved products);Wholesale of chemical products(Excluding hazardous chemicals);Biotechnology Consulting,communication service;Biotechnology Development Services;Biotechnology Transfer Services;Biotechnology Extension Services;Engineering and Technology Research and Experimental Development;Manufacturing of experimental analysis instruments;Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);New material technology development service;New material technical consultation,communication service;New material technology transfer service;trade agent;Commodity retail trade(Except for licensed and approved products);Trade Advisory Services;Import and export(Excluding franchised products);Technology Import and Export

Beijing Zhongyi Kangwei Medical Equipment Co., Ltd., established on 2014-10-13, The scope of business includes the production of medical devices Class I:Ι-6840In vitro diagnostic reagents;technology development,transfer,Serve;retail chemical products,Equipment,hardware(E-bike not included),computer,Software and Auxiliary Equipment,electronic product,knitted goods,clothing,shoes and hats,household items,stationery,crafts,flowers;Sales of medical devices(limit Ι,Class II);Economic and Trade Consulting;buisness planning;Business Management Consulting;translation service;Conference Services(No board and lodging);Undertake the exhibition;design,make,acting,Place an ad;graphic design,make;print service;Import and export;Technology Import and Export;Agent import and export;Organize cultural and artistic exchange activities(without show);Repair medical equipment;rental medical equipment,computer,communication equipment;Sales of Class III Medical Devices;Production of Class III medical devices;Engineering Investigation;engineering design.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of Class III medical devices,Sales of Class III Medical Devices,Engineering Investigation,Engineering design and projects subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Jiaxing Fraser Gene Information Co., Ltd., established on 2018-04-26, Business scope includes research and development of genetic information analysis technology,technology transfer;Gene information software development;Gene information consultation;Biotechnology R&D;Biological reagent research and development,technology transfer,technical consulting;Sales of biological reagent consumables;Engaged in the import and export of goods and technology(Goods and technologies prohibited by the state from import and export are not included).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Personal Biotechnology Co. Ltd. manufactures nutritional beauty products. Its products include high throughput sequencing, conventional molecular biology services, and conventional sequencing and synthesis. The company was founded in April 2011 and is headquartered in Shanghai, China.

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

Jiangsu Medical Union Biotechnology Co., Ltd., established on 2016-04-13, Business scope includes licensed projects:medical service;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Medical Research and Experimental Development;Sales of Class I Medical Devices;Production of Class I Medical Devices;Information security equipment sales;New material technology promotion service;Artificial intelligence theory and algorithm software development;Engineering and Technology Research and Experimental Development;Experimental analysis instrument sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

GENE DENOVO provides omics sequencing and bioinformatics analysis services. It is a genome sequencing, medical consultation, and health information management company. For inquiries, email, telephone numbers, and physical addresses are available on their website.

Berry Genomics Co., Ltd. engages in the gene detection and sales of equipment and reagents of high-throughput sequencing technology. The genetic testing includes medical products and services, and basic research services. Medical products and services are divided into medical testing services, reagent sales, and equipment sales. Medical testing services are mainly divided into two applications: genetics and oncology. The company was founded on April 14, 1997 and is headquartered in Beijing, China.